(Q54513121)

30 May 2018

reason for preferred rank

title

Cytokine inhibitors: soluble tumor necrosis factor receptor 1 and interleukin-1 receptor antagonist in Behçet’s disease (English)

1 reference

https://api.crossref.org/works/10.1007/S00296-003-0400-6

29 March 2024

Cytokine inhibitors: soluble tumor necrosis factor receptor 1 and interleukin-1 receptor antagonist in Behçet's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14600787

29 March 2024

0 references

1 reference

https://api.crossref.org/works/10.1007/S00296-003-0400-6

29 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00296-003-0400-6

29 March 2024

author name string

Nurşen Düzgün

1

1 reference

30 May 2018

Ergin Ayaşlioğlu

2

1 reference

30 May 2018

Hüseyin Tutkak

3

1 reference

30 May 2018

Olcay T. Aydintuğ

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14600787

29 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14600787

29 March 2024

publication date

5 November 2003

1 reference

30 May 2018

full work available at URL

http://link.springer.com/content/pdf/10.1007/s00296-003-0400-6.pdf

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1007/S00296-003-0400-6

http://link.springer.com/article/10.1007/s00296-003-0400-6/fulltext.html

29 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00296-003-0400-6

http://link.springer.com/content/pdf/10.1007/s00296-003-0400-6

29 March 2024

1 reference

https://api.crossref.org/works/10.1007/S00296-003-0400-6

Rheumatology International

29 March 2024

published in

1 reference

30 May 2018

volume

25

1 reference

30 May 2018

issue

1

1 reference

30 May 2018

page(s)

1-5

1 reference

30 May 2018

https://scigraph.springernature.com/pub.10.1007/s00296-003-0400-6

exact match

0 references

cites work

Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behçet's disease

1 reference

12 December 2020

Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease

1 reference

12 December 2020

Role of gammadelta T lymphocytes in the development of Behçet's disease

1 reference

12 December 2020

Anti-MHC autoimmunity in Behçet's disease: T cell responses to an HLA-B-derived peptide cross-reactive with retinal-S antigen in patients with uveitis

1 reference

12 December 2020

Interleukin-1 and interleukin-1 receptor antagonist.

1 reference

12 December 2020

Elevated serum interleukin 1 receptors and interleukin 1B in patients with Behçet's disease: correlations with disease activity and severity

1 reference

12 December 2020

Synovial interleukin-1 receptor antagonist and interleukin-1 balance in rheumatoid arthritis

1 reference

12 December 2020

Tumour necrosis factor alpha and its soluble receptors in juvenile chronic arthritis

1 reference

12 December 2020

Systemic levels of the T cell regulatory cytokines IL-10 and IL-12 in Bechçet's disease; soluble TNFR-75 as a biological marker of disease activity

1 reference

12 December 2020

[Soluble receptors of TNF-alpha in rheumatoid arthritis]

1 reference

12 December 2020

TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation

1 reference

12 December 2020

Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases

1 reference

12 December 2020

The mode of action of cytokine inhibitors

1 reference

12 December 2020

Endotoxin-stimulated human monocyte secretion of interleukin 1, tumour necrosis factor alpha, and prostaglandin E2 shows stable interindividual differences.

1 reference

12 December 2020

Cytokines in Behçet's disease

1 reference

12 December 2020

Production of TNF-alpha and IL-1 in active Behçet's disease

1 reference

12 December 2020

1 reference

12 December 2020

Interleukin-1 receptor antagonist in patients with active systemic lupus erythematosus. Enhanced production by monocytes and correlation with disease activity

1 reference

12 December 2020

Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behçet's disease. A comparative study with familial Mediterranean fever and healthy subjects.

1 reference

12 December 2020

Elevated levels of soluble intercellular adhesion molecule-1 correlate with disease activity in Behçet's disease

1 reference

12 December 2020

Interleukin-1 receptor antagonist

1 reference

12 December 2020

Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies

1 reference

12 December 2020

Correlation between serum levels of soluble tumor necrosis factor receptor and disease activity in systemic lupus erythematosus

1 reference

12 December 2020

Interleukin-1 receptor antagonist

1 reference

12 December 2020

TNF, soluble IL-2R and soluble CD-8 in Behçet's disease

1 reference

12 December 2020

Elevated serum levels of interleukin-1 receptor antagonist in polymyositis/dermatomyositis. A biologic marker of disease activity with a possible role in the lack of acute-phase protein response

1 reference

12 December 2020

Dermatologische Wochenschrift

1

36

1152

Behçet

1937

1 reference

https://api.crossref.org/works/10.1007/S00296-003-0400-6

29 March 2024

14

24

128

Turan

1997

1 reference

https://api.crossref.org/works/10.1007/S00296-003-0400-6

Gammadelta T cells in Behçet's disease (BD) and recurrent aphthous stomatitis (RAS)

29 March 2024

18

1 reference

https://api.crossref.org/works/10.1007/S00296-003-0400-6

29 March 2024

19

23

321

Sayinalp

1996

1 reference

https://api.crossref.org/works/10.1007/S00296-003-0400-6

29 March 2024

20

17

1107

Akoğlu

1990

1 reference

https://api.crossref.org/works/10.1007/S00296-003-0400-6

29 March 2024

22

17

1428

Hamzaoui

1990

1 reference

https://api.crossref.org/works/10.1007/S00296-003-0400-6

29 March 2024

23

20

1544

MegeJL,

1993

1 reference

https://api.crossref.org/works/10.1007/S00296-003-0400-6

29 March 2024

Identifiers

1 reference

30 May 2018

1 reference

30 May 2018